Purchase Order 75N93020P00189
Award Date 12/31/19
Potential Completion Date 12/30/20
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $20,000 firm fixed price purchase order to Genscript USA Inc. to provide custom gene synthesis services. The contract will support NIH's research efforts at its Bethesda, Maryland campus through December 31, 2023. Genscript will deliver custom gene synthesis products to NIH researchers as part of the Institute's work to advance understanding of diseases...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, for custom gene synthesis services. The contract has a potential value of $21,275.80 and a completion date of August 19, 2020. Genscript, based in Piscataway, New Jersey, specializes in gene synthesis, gene editing, custom protein and...
- This federal contract award to Genscript USA Inc. is for $182,897.61 to provide custom gene synthesis services to the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The contract is a firm fixed-price purchase order with no set-aside designation, and the services include DNA synthesis, subcloning, and plasmid preparation to support HIV research being conducted at the NIH...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Genscript USA Inc., a biotechnology company, for the provision of DNA expression constructs. The contract has a potential value of $12,475.22 and a completion date of November 2, 2023. Genscript has provided similar services to federal agencies in the past, supporting biomedical research and public health initiatives...
- Genscript USA Incorporated will provide gene synthesis and vector ark cloning services to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Under the terms of a $12,108 firm fixed price purchase order, Genscript will deliver the requested products and services between September 2023 and September 2024. As the prime contractor, Genscript will leverage its expertise...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,833.25 contract is for custom gene synthesis services to support NIAID's biomedical research and public health initiatives. While the award does not have a set-aside designation, Genscript has previously received some small business...
- This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, is for $20,000.00 in custom gene synthesis and expression services provided by Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. While the original solicitation is not provided, the award likely...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $17,709 purchase order to Genscript USA Inc. to provide custom gene synthesis and expression services in support of its research efforts. The firm fixed price contract has a period of performance from September 18, 2023 through December 31, 2023 and will be carried out by Genscript at its facility located in Bethesda, Maryland. No major subcontractors or set aside designations were identified....